In Vitro Diagnostics Market Research Reports & Industry Analysis

Publications found: 47,216
Sort by:

2022 New Zealand Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Nicaragua Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Nigeria Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Norway Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Oman Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Pakistan Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Panama Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Paraguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Peru Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Philippines Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Poland Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Portugal Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Puerto Rico Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Qatar Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Romania Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Russia Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Saudi Arabia Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Serbia Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Singapore Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Slovakia Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Slovenia Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 South Africa Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 South Korea Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Spain Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 2,850.00

LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the Spanish immunodiagnostic market during the next five years. The report is available by section, an...

September 2022 -

2022 Sweden Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Switzerland Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Taiwan Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Thailand Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Turkey Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 UK Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 2,850.00

LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the UK immunodiagnostic market during the next five years. The report is available by section, and can...

September 2022 -

2022 Ukraine Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 US Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 2,850.00

LeadingMarketResearch’s new report is a study of the major business opportunities emerging in the U.S. immunodiagnostic market during the next five years. The report is available by section, and can b...

September 2022 -

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests - High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

US$ 1,850.00

This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and i...

September 2022 -

2021-2026 Asia-Pacific Blood Typing, Grouping and Infectious Disease NAT Screening Market-18 Countries-Supplier Shares, Volume and Sales Segment Forecasts for over 40 Individual Tests

US$ 6,500.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. The report is available by section, and can be customized to specific...

September 2022 -

2021-2026 Australia Blood Typing, Grouping and Infectious Disease NAT Screening Market-Supplier Shares, Volume and Sales Segment Forecasts for over 40 Individual Tests

US$ 950.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. The report is available by section, and can be customized to specific...

September 2022 -

2021-2026 Austria Blood Typing, Grouping and Infectious Disease NAT Screening Market-Supplier Shares, Volume and Sales Segment Forecasts for over 40 Individual Tests

US$ 950.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. The report is available by section, and can be customized to specific...

September 2022 -

2021-2026 Bahrain Blood Typing, Grouping and Infectious Disease NAT Screening Market-Supplier Shares, Volume and Sales Segment Forecasts for over 40 Individual Tests

US$ 950.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. The report is available by section, and can be customized to specific...

September 2022 -

2021-2026 Bangladesh Blood Typing, Grouping and Infectious Disease NAT Screening Market-Supplier Shares, Volume and Sales Segment Forecasts for over 40 Individual Tests

US$ 950.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. The report is available by section, and can be customized to specific...

September 2022 -

2021-2026 Belgium Blood Typing, Grouping and Infectious Disease NAT Screening Market-Supplier Shares, Volume and Sales Segment Forecasts for over 40 Individual Tests

US$ 950.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. The report is available by section, and can be customized to specific...

September 2022 -

2021-2026 Brazil Blood Typing, Grouping and Infectious Disease NAT Screening Market-Supplier Shares, Volume and Sales Segment Forecasts for over 40 Individual Tests

US$ 950.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. The report is available by section, and can be customized to specific...

September 2022 -

2021-2026 Bulgaria Blood Typing, Grouping and Infectious Disease NAT Screening Market-Supplier Shares, Volume and Sales Segment Forecasts for over 40 Individual Tests

US$ 950.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. The report is available by section, and can be customized to specific...

September 2022 -

2021-2026 Canada Blood Typing, Grouping and Infectious Disease NAT Screening Market-Supplier Shares, Volume and Sales Segment Forecasts for over 40 Individual Tests

US$ 950.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. The report is available by section, and can be customized to specific...

September 2022 -

2021-2026 Chile Blood Typing, Grouping and Infectious Disease NAT Screening Market-Supplier Shares, Volume and Sales Segment Forecasts for over 40 Individual Tests

US$ 950.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. The report is available by section, and can be customized to specific...

September 2022 -

2021-2026 China Blood Typing, Grouping and Infectious Disease NAT Screening Market-Supplier Shares, Volume and Sales Segment Forecasts for over 40 Individual Tests

US$ 950.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. The report is available by section, and can be customized to specific...

September 2022 -

2021-2026 Colombia Blood Typing, Grouping and Infectious Disease NAT Screening Market-Supplier Shares, Volume and Sales Segment Forecasts for over 40 Individual Tests

US$ 950.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. The report is available by section, and can be customized to specific...

September 2022 -

2021-2026 Croatia Blood Typing, Grouping and Infectious Disease NAT Screening Market-Supplier Shares, Volume and Sales Segment Forecasts for over 40 Individual Tests

US$ 950.00

This unique report from LeadingMarketResearch.com provides information and analysisnot available from any other published source. The report is available by section, and can be customized to specific...

September 2022 -

Filters

Search

Categories

268
192
506
740
1,080
42,070
1,037
1,323

Publishers

254
303
32
1,840
173
119
161
31
32
105
1
63
281
68
12
1
1
15
19
62
1
204
1
2
2
52
3
1
4
6
10
12
32
2
6
19
36
1,950
7
5
3
40,959
64
9
3
3
164
13
2
4
6
21
7
2
5
23

Regions

15
1
136
134
133
133
133
137
137
136
136
136
136
136
136
135
135
135
134
133
130
129
217
198
187
186
15
100
183
14
170
23,305
419
188
186
186
185
185
185
185
185
184
184
183
183
183
183
183
183
183
182
182
182
182
182
181
180
180
136
136
4
3
2
203
195
192
192
191
191
190
190
190
190
190
189
189
189
189
189
189
188
188
188
188
188
187
187
187
187
187
186
185
184
182
104
102
101
100
100
205
213
898
1,222
964
961
958
949
946
933

Price

—

Date

—

Pages

—

Offers